Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-25T04:24:05.572Z Has data issue: false hasContentIssue false
  • English
  • Français

Changes in the epidemiology of ventilator-associated events over the course of the coronavirus disease 2019 (COVID-19) pandemic

Part of: SARS-CoV-2/COVID-19

Published online by Cambridge University Press:  27 October 2021

Jeremy F. Weinberger Open the ORCID record for Jeremy F. Weinberger [Opens in a new window] ,
Chanu Rhee Open the ORCID record for Chanu Rhee [Opens in a new window] ,
Michael Klompas Open the ORCID record for Michael Klompas [Opens in a new window]  and
for the CDC Prevention Epicenters Program
Jeremy F. Weinberger*
Affiliation:
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts Division of Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital, Boston, Massachusetts
Chanu Rhee
Affiliation:
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, Massachusetts
Michael Klompas
Affiliation:
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, Massachusetts
*
Author for correspondence: Jeremy F. Weinberger, E-mail: JWeinberger@tuftsmedicalcenter.org
Get access Rights & Permissions [Opens in a new window]

Abstract

Management of critically ill coronavirus disease 2019 (COVID-19) patients has evolved considerably during the pandemic. We investigated rates and causes of ventilator-associated events (VAEs) in COVID-19 patients in the late versus early waves in 4 Massachusetts hospitals. VAE rates per episode decreased, rates per ventilator day were stable, and most cases were caused by acute respiratory distress syndrome (ARDS).

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 44 , Issue 2 , February 2023 , pp. 305 - 307
Check for updates
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Anesi, GL, Jablonski, J, Harhay, MO, et al. Characteristics, outcomes, and trends of patients with COVID-19–related critical illness at a learning health system in the United States. Ann Intern Med 2021;174:613–621.CrossRefGoogle Scholar
Kurtz, P, Bastos, LSL, Dantas, LF, et al. Evolving changes in mortality of 13,301 critically ill adult patients with COVID-19 over 8 months. Intensive Care Med 2021;47:538–548.CrossRefGoogle Scholar
Papoutsi, E, Giannakoulis, VG, Xourgia, E, Routsi, C, Kotanidou, A, Siempos, II. Effect of timing of intubation on clinical outcomes of critically ill patients with COVID-19: a systematic review and meta-analysis of non-randomized cohort studies. Crit Care 2021;25:121.CrossRefGoogle ScholarPubMed
Ventilator-associated event (VAE) device-associated module. Centers for Disease Control and Prevention website. https://www.cdc.gov/nhsn/pdfs/pscmanual/10-vae_final.pdf 2021. Published January 2021. Accessed October 26, 2021.Google Scholar
Kerlin, MP, Trick, WE, Anderson, DJ, et al. Interrater reliability of surveillance for ventilator-associated events and pneumonia. Infect Control Hosp Epidemiol 2017;38:172–178.CrossRefGoogle ScholarPubMed
Weinberger, J, Rhee, C, Klompas, M. Incidence, characteristics, and outcomes of ventilator-associated events during the COVID-19 pandemic. Ann Am Thorac Soc 2021. doi: 10.1513/AnnalsATS.202103-364OC.Google Scholar
Cocoros, NM, Klompas, M. Ventilator-associated events and their prevention. Infect Dis Clin N Am 2016;30:887–908.CrossRefGoogle Scholar
Mellado-Artigas, R, Ferreyro, BL, Angriman, F, et al. High-flow nasal oxygen in patients with COVID-19–associated acute respiratory failure. Crit Care 2021;25:58.CrossRefGoogle ScholarPubMed
Investigators, R-C, Gordon, AC, Mouncey, PR, et al. Interleukin-6 receptor antagonists in critically ill patients with COVID-19. N Engl J Med 2021;384:1491–1502.CrossRefGoogle Scholar
Tomazini, BM, Maia, IS, Cavalcanti, AB, et al. Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial. JAMA 2020;324:1307–1316.CrossRefGoogle ScholarPubMed